Skip to Main content Skip to Navigation
Journal articles

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study

Benedicte Caron 1, 2 Laurent Peyrin-Biroulet 3 Benjamin Pariente 4 Yoram Bouhnik 5 Philippe Seksik 6, 7 Guillaume Bouguen 8 Ludovic Caillo 9 David Laharie 10 Franck Carbonnel 11, 12 Romain Altwegg 13 Catherine Reenaers 14 Mélanie Serrero 15 Caroline Trang-Poisson 16 Stephane Nancey 17 Jérome Filippi 18 Vered Abitbol 19 Guillaume Savoye 20, 21, 22, 23 Lucine Vuitton 24 Stephanie Viennot 25 Mathurin Fumery 26 Maud Reymond 27 Jean-Pierre Bronowicki 3 Jean-Marie Reimund 1, 2 Aurélien Amiot 28
Complete list of metadatas

https://hal-normandie-univ.archives-ouvertes.fr/hal-02363537
Contributor : Sabine Douville <>
Submitted on : Thursday, November 14, 2019 - 2:31:55 PM
Last modification on : Wednesday, October 14, 2020 - 3:11:48 AM

Links full text

Identifiers

Citation

Benedicte Caron, Laurent Peyrin-Biroulet, Benjamin Pariente, Yoram Bouhnik, Philippe Seksik, et al.. Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study. Journal of Crohn's and Colitis, Elsevier - Oxford University Press, 2019, 13 (10), pp.1239-1247. ⟨10.1093/ecco-jcc/jjz088⟩. ⟨hal-02363537⟩

Share

Metrics

Record views

392